Answers are grounded in this paper and cite their sources.
Observational analysis discovers dose heterogeneity in liver tumors and adjacent tissue, suggesting clinical implications for treatment outcomes.
TARE induces heterogeneous dose distributions in both liver tumors and nontumor target liver at a scale below the resolution of nuclear imaging. Although these findings provide insight into microsphere distribution and dose heterogeneity, the clinical significance of fine-scale dose heterogeneity and its potential impact on treatment outcomes remains uncertain and warrants further investigation.
No takes yet. Share an insight, caveat, or question.
Brekel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: